TABLE 1 Global Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 2 Global Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 3 Global Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 4 North America Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 5 North America Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 6 North America Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 7 U.S. Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 8 U.S. Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 9 U.S. Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 10 Canada Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 11 Canada Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 12 Canada Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 13 Rest of North America Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 14 Rest of North America Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 15 Rest of North America Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 16 UK and European Union Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 17 UK and European Union Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 18 UK and European Union Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 19 UK Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 20 UK Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 21 UK Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 22 Germany Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 23 Germany Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 24 Germany Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 25 Spain Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 26 Spain Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 27 Spain Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 28 Italy Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 29 Italy Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 30 Italy Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 31 France Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 32 France Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 33 France Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 34 Rest of Europe Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 35 Rest of Europe Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 36 Rest of Europe Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 37 Asia Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 38 Asia Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 39 Asia Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 40 China Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 41 China Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 42 China Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 43 Japan Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 44 Japan Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 45 Japan Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 46 India Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 47 India Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 48 India Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 49 Australia Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 50 Australia Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 51 Australia Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 52 South Korea Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 53 South Korea Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 54 South Korea Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 55 Latin America Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 56 Latin America Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 57 Latin America Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 58 Brazil Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 59 Brazil Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 60 Brazil Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 61 Mexico Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 62 Mexico Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 63 Mexico Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 64 Rest of Latin America Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 65 Rest of Latin America Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 66 Rest of Latin America Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 67 Middle East and Africa Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 68 Middle East and Africa Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 69 Middle East and Africa Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 70 GCC Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 71 GCC Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 72 GCC Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 73 South Africa Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 74 South Africa Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 75 South Africa Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 76 North Africa Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 77 North Africa Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 78 North Africa Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 79 Turkey Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 80 Turkey Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 81 Turkey Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
TABLE 82 Rest of Middle East and Africa Biodegradable Stents Market By Stent Type, 2022-2032, USD (Million)
TABLE 83 Rest of Middle East and Africa Biodegradable Stents Market By Material Type, 2022-2032, USD (Million)
TABLE 84 Rest of Middle East and Africa Biodegradable Stents Market By End-user, 2022-2032, USD (Million)
Market Overview
The biodegradable stents market encompasses the development, production, and sales of absorbable stents that are used to treat cardiovascular and other artery-related diseases. Unlike traditional metal stents that remain in the body indefinitely, biodegradable stents are designed to dissolve or be absorbed within the body over time, reducing the risk of long-term complications such as stent thrombosis. These stents are primarily made from biodegradable polymers and metals that ensure they maintain structural integrity long enough to treat the disease effectively before they degrade safely and harmlessly. Biodegradable stents are increasingly preferred in interventions like angioplasty because they offer temporary support to blood vessels until they can remain open on their own. Once their task is completed, these stents degrade, thereby eliminating the need for additional surgery to remove the stent and reducing the patient's exposure to chronic foreign bodies. This technology is particularly significant in the treatment of coronary artery diseases, peripheral artery diseases, and in pediatric patients where vessel growth is still expected. The use of biodegradable materials is also being explored in other areas such as the urinary tract, gastrointestinal tract, and airways. The global biodegradable stents market is projected to grow at a compound annual growth rate (CAGR) of 7.5%. This robust growth is driven by the rising prevalence of coronary and peripheral artery diseases globally, coupled with an aging population that is more susceptible to such health issues. Advances in biomedical engineering that improve the performance and safety of these stents further encourage their adoption. Additionally, growing patient and physician preference for minimally invasive procedures that require less recovery time and carry lower risk of complications is also contributing to the expansion of this market.
Rising Incidence of Coronary Artery Diseases Drives Market Growth
A key driver for the biodegradable stents market is the increasing global incidence of coronary artery diseases (CAD), which are primarily caused by the buildup of cholesterol-laden plaques in the coronary arteries. As lifestyle-related risks such as obesity, diabetes, and sedentary habits become more prevalent worldwide, the number of individuals suffering from CAD rises significantly. This increasing patient population necessitates effective, minimally invasive solutions for managing CAD, bolstering demand for biodegradable stents. These devices are seen as an advantageous alternative to permanent metallic stents, as they reduce long-term complications and eliminate the need for future surgical interventions related to stent removal.
Technological Innovations Present Market Opportunities
The biodegradable stents market is poised for expansion through technological innovations that enhance stent functionality and patient safety. Current research and development efforts are focused on improving the materials used in biodegradable stents to optimize their absorption rates and mechanical properties. Innovations such as drug-eluting biodegradable stents, which slowly release medication to prevent the artery from closing again, represent significant opportunities. These advancements promise to increase the efficacy of stents in complex and high-risk lesions, which can extend their applicability and appeal in the broader vascular treatment landscape.
High Cost of Biodegradable Stents Restrains Market Growth
Despite their benefits, a major restraint for the biodegradable stents market is the high cost associated with their development and implementation. Biodegradable stents are typically more expensive than their metallic counterparts due to the sophisticated materials and manufacturing processes required. This cost factor can be prohibitive for widespread adoption, particularly in developing countries where healthcare spending is limited and there is a greater sensitivity to the price of medical devices.
Regulatory Hurdles Challenge Market Progress
Navigating the regulatory landscape poses a significant challenge in the biodegradable stents market. Regulatory approvals for medical devices, particularly those that are implantable and biodegradable, can be stringent and time-consuming. Each country's health authority has its own set of requirements and processes for the approval of new medical devices, which can vary widely and complicate the path to market entry. For biodegradable stents, demonstrating safety and efficacy through clinical trials to the satisfaction of regulatory bodies is especially critical but also burdensome. Delays in approvals can impede market access and affect the overall adoption rate of new technologies within this sector.
Market Segmentation by Stent Type
Coronary artery stents account for the highest revenue within the market, driven by the high prevalence of coronary artery diseases globally. These stents are primarily utilized in angioplasty procedures to treat narrowed or blocked coronary arteries, a common condition as populations age and lifestyle diseases such as diabetes and obesity increase. Conversely, peripheral artery stents are anticipated to exhibit the highest CAGR. This growth is attributed to the rising awareness and improving diagnostic technologies for peripheral artery diseases, which often go undiagnosed until they become severe, combined with an expanding range of applications for peripheral stenting in areas like the legs, arms, and renal arteries.
Market Segmentation by Material Type
Polymer-based stents currently generate the highest revenue due to their favorable properties, such as flexibility and a lower inflammatory response, which are critical for patient recovery and comfort. These stents are designed to degrade at a controlled rate, matching the healing process of the vessel tissue. Metal-based stents, while less commonly used currently, are expected to experience the highest CAGR. Innovations in biodegradable metal alloys, such as magnesium, which provide structural support similar to traditional stents but with the advantage of degrading into non-toxic elements absorbed or excreted by the body, are driving interest and potential growth in this segment.
Market Segmentation by Region
In the biodegradable stents market, geographic trends indicate that North America held the highest revenue percentage in 2023, driven by advanced healthcare infrastructure, high healthcare expenditure, and an established regulatory framework that supports the adoption of new medical technologies. Additionally, the presence of a large patient base suffering from cardiovascular diseases and the availability of cutting-edge medical technologies further strengthen the region's dominance. However, the Asia-Pacific region is expected to register the highest CAGR from 2024 to 2032. This anticipated growth is fueled by increasing healthcare expenditure, rising awareness of cardiovascular diseases, and improving healthcare facilities in emerging economies such as China and India. The expansion of healthcare coverage and the growing middle-class population in these countries are also expected to boost demand for advanced medical solutions, including biodegradable stents.
Competitive Trends
Competitive trends in the market are shaped by strategic initiatives undertaken by key players such as Boston Scientific, Inc., Abbott, Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd., Biotronik, Terumo Corporation, Biosensors International Group, ELLA - CS, s.r.o., and SMT. In 2023, these companies focused on expanding their product portfolios, enhancing technological advancements, and entering new markets. Significant investments were made in research and development to innovate and improve the efficacy and safety of biodegradable stents. From 2024 to 2032, these players are expected to continue leveraging technological advancements to develop stents that offer better patient outcomes and longer degradation times. Strategic partnerships, mergers, and acquisitions are anticipated to be key strategies to expand their global footprint and enhance market share. Additionally, these companies are likely to increase their focus on emerging markets, where the demand for minimally invasive surgeries is growing rapidly, driving further expansion and competition in the global market.
